Shukra Pharmaceuticals
add_icon

Shukra Pharmaceuticals

39.90
+1.54
(4.01%)
Market Cap
₹- Cr
PE Ratio
-
Volume
3,37,380.00
Day High - Low
₹40.20 - ₹37.80
52W High-Low
₹44.31 - ₹6.00
hide
Key Fundamentals
Add Ratio
split_icon_default
Market Cap
- Cr
EPS
-
PB Ratio
-
Book Value
1.50
EBITDA
-
Dividend Yield
- %
Industry
Healthcare
ROE Growth %
-
Debt to Equity
-
Forecast For
Actual

Company News

View All News
Caret
positive
Shukra Pharmaceuticals Secures Authorization as Distributor for Defence Medical Equipment1 day ago
Shukra Pharmaceuticals Limited received authorization from Integra Medical Devices India Private Limited to act as the authorized distributor for all DGAFMS (Directorate General Armed Force Medical Services) purchases across India, valid until December 31, 2026. The authorization empowers the company to promote, market, and supply medical equipment to Defence Hospitals, Commands, and related Defence Organizations, expected to enhance revenue visibility and improve margins through premium medical device offerings.
neutral
Shukra Pharmaceuticals Seeks Shareholder Approval for Director's Continuation Beyond Age 751 day ago
Shukra Pharmaceuticals has issued a postal ballot notice seeking shareholder approval through special resolution for continuation of Mr. Jitendra Somchand Shah as Non-Executive Independent Director beyond age 75, which he attained on September 22, 2025. The e-voting process will commence on December 4, 2025 and conclude on January 3, 2026, with results to be declared by January 5, 2026.
neutral
Shukra Pharmaceuticals Seeks Shareholder Approval for Director's Continuation Beyond Age 755 days ago
Shukra Pharmaceuticals requires shareholder approval through postal ballot for continuation of Non-Executive Independent Director Mr. Jitendra Somchand Shah (DIN: 01609325) who attained age of 75 years on September 22, 2025. The approval is mandated under SEBI regulations for directors continuing beyond 75 years, with Shah having over 42 years of experience in marketing and business development.
View more
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
790.15
-
#1 -
-
-
-
-
34.61
699.20
-
#1 -
-
-
-
-
43.29
64.57
-
#1 -
-
-
-
-
21.03
554.80
-
#1 -
-
-
-
-
37.85
28,850.00
-
#1 -
-
-
-
-
39.24
42.05
-
#1 -
-
-
-
-
41.15
54.60
-
#1 -
-
-
-
-
42.72
5,001.00
-
#1 -
-
-
-
-
43.40
414.10
-
#1 -
-
-
-
-
43.97
26.95
-
#1 -
-
-
-
-
41.68
Growth Rate
Revenue Growth
-
Net Income Growth
-
Cash Flow Change
-
ROE
-
ROCE
-
EBITDA Margin (Avg.)
-

Yearly Financial Results

Annual Financials
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
TTM
Revenue
4
5
5
6
6
12
12
21
60
77
37
40
Expenses
3
4
4
4
4
10
10
18
54
55
20
23
EBITDA
1
1
2
2
2
2
2
3
7
22
17
17
Operating Profit %
-10 %
24 %
29 %
30 %
29 %
13 %
13 %
14 %
9 %
26 %
39 %
27 %
Depreciation
1
0
1
1
1
2
2
2
2
2
3
3
Interest
0
0
0
0
0
0
0
0
0
0
1
1
Profit Before Tax
0
0
1
1
1
0
0
1
4
20
13
13
Tax
0
0
1
0
0
0
-0
0
0
1
4
4
Net Profit
0
0
1
1
1
0
0
1
4
19
10
12
EPS in ₹
0.84
0.76
3.21
3.36
2.95
0.23
1.20
4.79
26.21
16.93
0.22
0.90

Balance Sheet

Balance Sheet
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Total Assets
18
17
19
24
28
34
36
35
75
78
87
Fixed Assets
10
10
10
14
16
17
18
18
20
20
19
Current Assets
7
6
7
8
11
15
16
16
53
56
65
Capital Work in Progress
2
2
2
2
2
2
2
2
2
2
2
Investments
0
0
0
0
0
0
0
0
0
0
0
Other Assets
7
6
7
8
11
15
16
16
53
56
65
Total Liabilities
18
17
19
24
28
34
36
35
75
78
87
Current Liabilities
1
1
2
3
4
7
7
12
43
14
17
Non Current Liabilities
4
3
3
6
9
11
13
6
7
6
7
Total Equity
14
14
15
15
15
15
16
16
25
58
63
Reserve & Surplus
12
13
13
13
14
14
14
15
21
47
19
Share Capital
2
2
2
2
2
2
2
2
4
11
44

Cash Flow

Cash Flow
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Net Cash Flow
0
1
-1
-1
0
-0
0
-0
4
6
2
Investing Activities
1
-0
-1
-5
-3
-3
-2
-2
-4
-1
-1
Operating Activities
-2
3
-0
1
0
1
1
8
3
-5
8
Financing Activities
1
-1
0
4
2
2
2
-7
5
12
-5

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Aug 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Sept 2025
Promoter
49.17 %
49.17 %
49.17 %
49.17 %
49.17 %
49.17 %
49.17 %
49.17 %
50.90 %
50.90 %
50.90 %
50.90 %
50.96 %
50.96 %
50.96 %
50.96 %
50.96 %
50.96 %
50.96 %
50.96 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
DIIs
0.80 %
0.80 %
0.80 %
0.80 %
0.80 %
0.80 %
0.80 %
0.80 %
0.11 %
0.11 %
0.11 %
0.11 %
0.11 %
0.11 %
0.11 %
0.11 %
0.11 %
0.11 %
0.11 %
0.11 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
33.02 %
33.02 %
32.90 %
32.86 %
32.83 %
32.81 %
33.00 %
33.06 %
29.14 %
29.10 %
29.11 %
29.14 %
28.94 %
9.79 %
9.19 %
9.25 %
9.41 %
9.29 %
28.69 %
9.20 %
Others
17.01 %
17.01 %
17.14 %
17.18 %
17.21 %
17.22 %
17.04 %
16.98 %
19.85 %
19.88 %
19.88 %
19.85 %
19.99 %
39.14 %
39.73 %
39.68 %
39.51 %
39.64 %
20.24 %
39.72 %
No of Share Holders
9,345
9,345
9,305
9,268
9,239
9,193
9,237
9,234
9,544
9,582
9,600
9,747
10,963
12,974
14,989
16,321
17,844
18,231
20,337
21,441

Dividend History

Annual Cash Flows 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Dividend Per Share (₹) 0.00 0.5 0.5 0.5 0.00 0.00 0.5 0.5 1 0.01
Dividend Yield (%) 0.00 156.25 263.16 208.33 0.00 0.00 42.74 6.13 4.58 0.03

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
19 Oct 2016 CHANGE OF NAME Change Of Name
NA
19 Oct 2016 0.33 0.33
22 Sept 2022 DIVIDEND Dividend
₹ 0.50 /share
22 Sept 2022 0.30 1.06
02 Feb 2023 RIGHTS Rights
6:1
02 Feb 2023 0.84 1.37
16 Sept 2023 DIVIDEND Dividend
₹ 0.50 /share
15 Sept 2023 2.58 4.56
20 Apr 2024 BONUS Bonus
3:1
19 Apr 2024 7.53 8.48
23 Aug 2024 EXTRAORDINARY GENERAL MEETING Extraordinary General Meeting
NA
23 Aug 2024 9.01 6.14
24 Sept 2024 DIVIDEND Dividend
₹ 1.00 /share
23 Sept 2024 10.69 6.36
30 Sept 2024 ANNUAL GENERAL MEETING Annual General Meeting
NA
30 Sept 2024 6.39 6.75
14 Nov 2024 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
14 Nov 2024 6.93 6.49
14 Feb 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
14 Feb 2025 23.34 21.09
29 Jan 2025 SPLIT Split
1:10
21 Mar 2025 22.45 22.45
29 May 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
29 May 2025 13.98 13.27
13 Aug 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
13 Aug 2025 20.70 18.68
18 Sept 2025 DIVIDEND Dividend
₹ 0.01 /share
18 Sept 2025 13.26 30.04
30 Sept 2025 ANNUAL GENERAL MEETING Annual General Meeting
NA
30 Sept 2025 26.22 35.16
01 Nov 2025 EXTRAORDINARY GENERAL MEETING Extraordinary General Meeting
NA
01 Nov 2025 34.45 41.01
13 Nov 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
13 Nov 2025 41.84 41.77

Announcements

Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_Order1 day ago
Shareholder Meeting / Postal Ballot-Notice of Postal Ballot1 day ago
Approval Of Continuation Of Directorship Of Mr. Jitendra Somchand Shah Non-Executive Independent Director Who Has Attained Age Of 75 Years On September 22 2025 Subject To Approval Of Shareholders.5 days ago
Outcome Of The Meeting Of The Board Of Directors Held On Saturday November 29 20255 days ago
Board Meeting Outcome for Outcome Of The Meetins Of The Board Of Directors Held On Saturdav. November 29.2025.5 days ago
Announcement under Regulation 30 (LODR)-Newspaper PublicationNov 14, 2025
Un-Audited Financial Results Of The Company For The Second Quarter And Half Year Ended September 30 2025 Along With The Auditors Limited Review Reports In Accordance With The Provisions Of Regulation 33 Of The SEBI Listing Regulations.Nov 13, 2025
Board Meeting Outcome for Outcome Of Board Meeting Held On November 13 2025.Nov 13, 2025
Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 - Incorporation Of Subsidiary Company.Nov 10, 2025
Voting Result Along With Scrutinizer Report Of Extra Ordinary General Meeting (EOGM) Of The Company Held On November 01 2025.Nov 01, 2025
Shareholder Meeting / Postal Ballot-Outcome of EGMNov 01, 2025
Board Meeting Intimation for Unaudited Financial Result For The Half Year Ended On 30TH September 2025 Along With The Auditors Limited Review Report.Oct 31, 2025
Receipt Of Distributorship RightsOct 31, 2025
Intimation U/R 30 Of SEBI LODR- Incorporation Of Subsidiary CompanyOct 24, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationOct 15, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Oct 08, 2025
Authorization Received From Meril Healthcare Private Limited For The Project Of ROBOTIC ASSISTED SURGERY SYSTEM FOR ORTHOPEDICS At Directorate General Armed Forces Medical Services And INHS Asvini Maharashtra.Oct 08, 2025
Notice Of Extra Ordinary General Meeting Of Shukra Pharmaceuticals Limited To Be Held On Saturday November 01 2025.Oct 07, 2025
Board Meeting Outcome for Revised Outcome Of The Meeting Of The Board Of Directors Held On Friday October 03 2025.Oct 04, 2025
Announcement under Regulation 30 (LODR)-Issue of SecuritiesOct 03, 2025
Board Meeting Outcome for Outcome Of The Meeting Of The Board Of Directors Held On Friday October 03 2025.Oct 03, 2025
Voting Result Along With Scrutinizer Report Of 32Nd Annual General Meeting (AGM) Of The Company Held On September 30 2025.Oct 03, 2025
Shareholder Meeting / Postal Ballot-Outcome of AGMSep 30, 2025
Closure of Trading WindowSep 29, 2025
Board Meeting Intimation for Preferential Issue Of Warrants As Per Chapter V And In Accordance With Securities And Exchange Board Of India (Issue Of Capital And Disclosure Requirements) Regulations 2018 To Promoters Subject To Approval Of Shareholders.Sep 22, 2025
Intimation Of Book Closure And Record Date Pursuant To Regulation 42 Of SEBI Listing Regulations For Annual General Meeting Of The Company.Sep 12, 2025
Intimation Of Record Date For Final Dividend For Financial Year 2024-2025.Sep 12, 2025
Corrigendum To The Notice Of 32ND Annual General Meeting And Annual Report (2024-25) Of The CompanySep 12, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationSep 10, 2025
Announcement Under Regulation 30 Of SEBI (LODR)- Strategic PAN India Distribution Tie-UpSep 10, 2025
Reg. 34 (1) Annual Report.Sep 08, 2025
Submission Of Notice Of 32Nd AGM Of The Companny.Sep 08, 2025
Board Meeting Outcome for Outcome Of The Board Of Directors Of The Company.Sep 08, 2025
Appointment Of Secretarial Auditor Of The Company Subject To Approval From The Members Of The Company.Aug 30, 2025
Announcement under Regulation 30 (LODR)-Appointment of Statutory Auditor/sAug 30, 2025
Board Meeting Outcome for Outcome Of Meeting Of Board Of Directors Held On Today I.E. August 30 2025Aug 30, 2025
Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_OrderAug 28, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 14, 2025
Un-Audited Financial Results Of The Company For The First Quarter Ended June 30 2025 Along With The Auditors Limited Review Reports In Accordance With The Provisions Of Regulation 33 Of The SEBI Listing Regulations.Aug 13, 2025
Board Meeting Outcome for Outcome Of The Meeting Of The Board Of Directors Held On Wednesday August 13 2025.Aug 13, 2025
Board Meeting Intimation for Meeting Of The Board Of Directors Of The Company Is Scheduled To Be Held On August 13 2025Jul 31, 2025
Announcement under Regulation 30 (LODR)-Memorandum of Understanding /AgreementsJul 26, 2025
Announcement under Regulation 30 (LODR)-Memorandum of Understanding /AgreementsJul 26, 2025
Announcement under Regulation 30 (LODR)-Memorandum of Understanding /AgreementsJul 25, 2025
Grant Of Distributorship RightsJul 21, 2025
Strategic Expansion Through Opening Of Branch Offices In Mumbai Gurgaon(NCR) Bangalore And KolkataJul 09, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jul 04, 2025
Closure of Trading WindowJun 28, 2025
Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_OrderJun 27, 2025
Corporate Action-Board approves DividendJun 04, 2025

Technical Indicators